Pharmacological interventions for the MATRICS cognitive domains in schizophrenia: what's the evidence?
Schizophrenia is a disabling, chronic psychiatric disorder with a prevalence rate of 0.5-1% in the general population. Symptoms include positive (e.g. delusions, hallucinations), negative (e.g. blunted affect, social withdrawal), as well as cognitive symptoms (e.g. memory and attention problems). Al...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2013-12-01
|
| Series: | Frontiers in Psychiatry |
| Subjects: | |
| Online Access: | http://journal.frontiersin.org/Journal/10.3389/fpsyt.2013.00157/full |